Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$103,125,594
-$4,097,410 QoQ
Shares Held
409,814
-16.9% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#250
of 4,176 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $750,511,239 across 12 Drug Manufacturers - General names. ABBV ranks #3 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
212,458 | $254,828,520 | |
| 2 | JNJ |
Johnson & Johnson
|
550,760 | $139,876,517 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
409,814 | $103,125,594 | |
| 4 | MRK |
Merck & Co., Inc.
|
565,110 | $72,616,635 | |
| 5 | AMGN |
Amgen Inc
|
138,472 | $50,143,480 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
284,053 | $35,887,256 | |
| 7 | PFE |
Pfizer Inc
|
1,303,824 | $31,396,081 | |
| 8 | AZN |
Astrazeneca PLC
|
149,538 | $28,355,395 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,125,594 | 409,814 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $107,223,004 | 493,002 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $116,342,309 | 509,179 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $120,930,563 | 522,288 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $98,530,808 | 530,820 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $103,078,182 | 491,973 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $89,128,278 | 501,566 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $97,606,662 | 494,261 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $86,897,349 | 506,631 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $88,567,977 | 486,370 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $77,689,715 | 501,321 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $76,038,785 | 510,122 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $70,243,371 | 521,364 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $83,981,296 | 526,958 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $86,017,892 | 532,256 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $72,836,974 | 542,709 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $84,009,178 | 548,506 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $90,803,160 | 560,133 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $52,887,104 | 390,599 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $43,054,692 | 399,135 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $46,124,953 | 409,490 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $45,539,949 | 420,809 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $45,940,991 | 428,754 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $39,193,196 | 447,462 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $45,252,929 | 460,918 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $29,042,485 | 381,185 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||